WO2024257009 - METHODS AND INTERMEDIATES FOR PREPARING COMPOUNDS
National phase entry is expected:
Publication Number
WO/2024/257009
Publication Date
19.12.2024
International Application No.
PCT/IB2024/055798
International Filing Date
13.06.2024
Title **
[English]
METHODS AND INTERMEDIATES FOR PREPARING COMPOUNDS
[French]
PROCÉDÉS ET INTERMÉDIAIRES POUR LA PRÉPARATION DE COMPOSÉS
Applicants **
VIIV HEALTHCARE UK (NO.5) LIMITED
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB
Inventors
BARRON, Benedict James
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB
FENNER, Sabine
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB
LEACH, Stuart Grahame
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB
ZAJAC, Matthew Allen
1250 South Collegeville Road
Global Patents UP4110
Collegeville, Pennsylvania 19426, US
Priority Data
63/508,278
15.06.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1315 | |
| EPO | Filing, Examination | 6620 | |
| Japan | Filing | 533 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2635 |
Total: 11678 USD
Abstract[English]
The disclosure relates to a process for the preparation of intermediates useful for preparing compounds that inhibit functions of the human immunodeficiency virus (HIV) during the virus replication cycle, such as disrupting functions of the capsid shell of HIV.[French]
La divulgation concerne un procédé de préparation d'intermédiaires utiles pour préparer des composés qui inhibent les fonctions du virus de l'immunodéficience humaine (VIH) pendant le cycle de réplication virale, par exemple par la perturbation des fonctions de la capside du VIH.